ALZECURE PHARMA (Germany) Probability of Future Stock Price Finishing Under 0.01
| AC6 Stock | EUR 0.28 0.02 6.67% |
ALZECURE |
ALZECURE PHARMA Target Price Odds to finish below 0.01
The tendency of ALZECURE Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to € 0.01 or more in 90 days |
| 0.28 | 90 days | 0.01 | near 1 |
Based on a normal probability distribution, the odds of ALZECURE PHARMA to drop to € 0.01 or more in 90 days from now is near 1 (This ALZECURE PHARMA AB probability density function shows the probability of ALZECURE Stock to fall within a particular range of prices over 90 days) . Probability of ALZECURE PHARMA AB price to stay between € 0.01 and its current price of €0.28 at the end of the 90-day period is about 82.93 .
Assuming the 90 days horizon ALZECURE PHARMA has a beta of 0.23. This suggests as returns on the market go up, ALZECURE PHARMA average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ALZECURE PHARMA AB will be expected to be much smaller as well. Moreover ALZECURE PHARMA AB has an alpha of 1.9486, implying that it can generate a 1.95 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). ALZECURE PHARMA Price Density |
| Price |
Predictive Modules for ALZECURE PHARMA
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ALZECURE PHARMA AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ALZECURE PHARMA Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ALZECURE PHARMA is not an exception. The market had few large corrections towards the ALZECURE PHARMA's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ALZECURE PHARMA AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ALZECURE PHARMA within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.95 | |
β | Beta against Dow Jones | 0.23 | |
σ | Overall volatility | 0.04 | |
Ir | Information ratio | 0.12 |
ALZECURE PHARMA Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ALZECURE PHARMA for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ALZECURE PHARMA AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ALZECURE PHARMA AB is way too risky over 90 days horizon | |
| ALZECURE PHARMA AB has some characteristics of a very speculative penny stock | |
| ALZECURE PHARMA AB appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (7.21 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| About 34.0% of the company shares are held by company insiders |
ALZECURE PHARMA Technical Analysis
ALZECURE PHARMA's future price can be derived by breaking down and analyzing its technical indicators over time. ALZECURE Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ALZECURE PHARMA AB. In general, you should focus on analyzing ALZECURE Stock price patterns and their correlations with different microeconomic environments and drivers.
ALZECURE PHARMA Predictive Forecast Models
ALZECURE PHARMA's time-series forecasting models is one of many ALZECURE PHARMA's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ALZECURE PHARMA's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about ALZECURE PHARMA AB
Checking the ongoing alerts about ALZECURE PHARMA for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ALZECURE PHARMA AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| ALZECURE PHARMA AB is way too risky over 90 days horizon | |
| ALZECURE PHARMA AB has some characteristics of a very speculative penny stock | |
| ALZECURE PHARMA AB appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (7.21 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| About 34.0% of the company shares are held by company insiders |
Other Information on Investing in ALZECURE Stock
ALZECURE PHARMA financial ratios help investors to determine whether ALZECURE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALZECURE with respect to the benefits of owning ALZECURE PHARMA security.